ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more.
Company Details
- Employees
- 79
- Founded
- -
- Address
- 219 Terry Ave N, Seattle,washington 98109,united States
- in****@****etx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- shapetx.com
- Keywords
- Gene Editing, Gene Therapy, RNA Editing.
- HQ
- Seattle, Washington
Shape Therapeutics Inc. Questions
Shape Therapeutics Inc.'s website is shapetx.com
Shape Therapeutics Inc.'s LinkedIn profile is https://www.linkedin.com/company/shapetx
Shape Therapeutics Inc. has
79 employees.
View email and phone details for 79
employees at Shape Therapeutics Inc..
Shape Therapeutics Inc.'s industry is
Biotechnology Research
Shape Therapeutics Inc.'s top competitors are
Parse Biosciences,
Curi Bio,
Sana Biotechnology, Inc.,
Outpace Bio,
Lumen Bioscience,
Tune Therapeutics,
A-Alpha Bio,
Sonoma Biotherapeutics, Inc.,
Umoja Biopharma,
Lyell Immunopharma.
Shape Therapeutics Inc.'s support email address is info@shapetx.com
Shape Therapeutics Inc.'s categories are Biotechnology Research
Shape Therapeutics Inc.'s founding year is 2018
